Issue 5, 2015

Design, synthesis and biological evaluation of thiourea and nicotinamide-containing sorafenib analogs as antitumor agents

Abstract

A series of thiourea and nicotinamide-containing sorafenib analogs (7a–n) were designed and synthesized and their antiproliferative activities were tested against HCT116, MDA-MB-231, PC-3 and HepG2 cell lines. Most of the compounds showed potent activities against the four cell lines, compound 7h showed better activities than sorafenib against all four cell lines, and compounds 7a and 7e showed better activities against HCT116 and MDA-MB-231 cell lines. The anti-angiogenic activities of 7e and 7h were also better than that of sorafenib in both in vitro HUVEC tube formationassay and ex vivo rat thoracic aorta ring assay.

Graphical abstract: Design, synthesis and biological evaluation of thiourea and nicotinamide-containing sorafenib analogs as antitumor agents

Supplementary files

Article information

Article type
Concise Article
Submitted
29 Nov 2014
Accepted
28 Feb 2015
First published
02 Mar 2015

Med. Chem. Commun., 2015,6, 867-870

Author version available

Design, synthesis and biological evaluation of thiourea and nicotinamide-containing sorafenib analogs as antitumor agents

X. Kong, Z. Yao, Z. He, W. Xu and J. Yao, Med. Chem. Commun., 2015, 6, 867 DOI: 10.1039/C4MD00536H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements